May 2012 Archives
Seventy-five years ago, physicians couldn't rely on a CT or MRI scan to help diagnose and treat brain and nervous system diseases. Surgery often focused on immediate, practical needs, and the technology was crude. Even then, however, the diagnostic and surgical skills required for neurologic diseases differed drastically from those of general surgery. "It became increasingly difficult for general surgeons and neurosurgeons to cover for each other and provide each other the disciplinary support they needed," explains Stephen Haines, M.D., head of neurosurgery at the University of Minnesota today.
Department of Neurosurgery chair Stephen Haines, M.D., often chats with the neurosurgery training program's oldest living graduate—his own father, a retired neurosurgeon who lives in upstate New York. Because the neurosurgery program has played such a key role in both Haineses’ lives, the two men wanted to give something back.
Support research into brain, nerve, and muscle disorders at the University of Minnesota and receive steady income for life with a charitable gift annuity. Through a simple contract, you agree to make a donation of cash, stocks, or other assets to the Minnesota Medical Foundation. In return, we agree to pay you a fixed amount each year for the rest of your life.
Sufferers of Parkinson's disease, ataxia, depression, and obsessive compulsive disorder take note: University of Minnesota scientists have taken an important leap forward in their effort to understand disorders that they believe are caused by faulty wiring deep in the brain. Center for Magnetic Resonance Research imaging expert Noam Harel, Ph.D., is in the spotlight after publishing research results in January about how, for the first time, he and his colleagues successfully mapped neural connections in the human basal ganglia.
In the fight against ataxia, the University of Minnesota sits at ground zero. Nowhere else in the world do all the pieces—research, education, clinical treatment, and fundraising—come together as they do in the Twin Cities, where both the National Ataxia Foundation (NAF) and the Bob Allison Ataxia Research Center (BAARC) are based. These organizations have long provided critical support for ataxia research at the University, where Institute for Translational Neuroscience director Harry T. Orr, Ph.D., has spent the past 25 years moving the fight forward. NAF and BAARC recently joined forces to provide Orr and his team with $100,000 to fund research focused on developing a drug to treat spinocerebellar ataxia type 1.
University of Minnesota scientists hope that two new studies will enhance understanding of the underlying causes of Parkinson's disease, potentially leading to the development of new drug therapies and treatment options for patients. In one study, neuroscientist Michael Lee, Ph.D., and his colleagues examined one of the obvious causes of the progression of Parkinson's: dying neurons in the patient's brain.

